Citations

Clear

127 citation(s) found for "Desai, Aakash P".

S1388 Comparative Outcomes of Laparoscopic vs Open IPAA in Patients With IBD: A Propensity Score-Matched Analysis
Khanna, Tushar, Nandish, Nilan, Tunio, Nahel A., Lichtenstein, Gary, Sehgal, Priya , Desai, Aakash

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S993-S993

10.14309/01.ajg.0001034920.12287.43 Get It

S1211 Higher Incidence of Recombinant Zoster Vaccination in Patients With Inflammatory Bowel Disease: A TriNetX Database Analysis
Wang, Yichen , Wang, Yichen, Huang, Yuting , Desai, Aakash , Hashash, Jana G. , Caldera, Freddy , Farraye, Francis A.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S860-S861

10.14309/01.ajg.0001034212.64995.d0 Get It

S1210 Lower Rates of Recurrent Herpes Zoster Complications in Patients With Inflammatory Bowel Disease Who Received Recombinant Zoster Vaccination: A Propensity Score Matched Analysis
Wang, Yichen , Desai, Aakash , Huang, Yuting , Hashash, Jana G. , Caldera, Freddy , Farraye, Francis A. , Wang, Yichen

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S860-S860

10.14309/01.ajg.0001034208.72019.63 Get It

S1107 Comparative Outcomes in Patients With Newly Diagnosed Inflammatory Bowel Disease With and Without Concurrent Eosinophilic Esophagitis: A Propensity-Matched Cohort Study
Tabaku, Fjona, Kochhar, Gursimran , Khataniar, Himsikhar , Desai, Aakash , Hashash, Jana G. , Farraye, Francis A.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S785-S786

10.14309/01.ajg.0001033796.26042.f5 Get It

S1105 Natural History and Predictors of Treatment Failure in Patients With Ulcerative Colitis on 5-Aminosalicylic Acid: A U.S. Population-Level Cohort Study
Kochhar, Gursimran , Khataniar, Himsikhar , Hashash, Jana G. , Farraye, Francis A. , Desai, Aakash

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S783-S784

10.14309/01.ajg.0001033788.76902.79 Get It

S1103 Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort Analysis
Kochhar, Gursimran , Khataniar, Himsikhar , Hashash, Jana G. , Farraye, Francis A. , Desai, Aakash

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S780-S781

10.14309/01.ajg.0001033780.31178.74 Get It

S1104 Updated Epidemiological Insights on the Association Between Eosinophilic Esophagitis and Inflammatory Bowel Disease: A United States Population-Based Cohort Study
Tabaku, Fjona, Kochhar, Gursimran , Khataniar, Himsikhar , Hashash, Jana G. , Farraye, Francis A. , Desai, Aakash

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S781-S782

10.14309/01.ajg.0001033784.60470.2a Get It

S1108 Efficacy of Turmeric (Curcumin) Plus Mesalamine in Ulcerative Colitis: A Propensity-Matched Cohort Study
Tabaku, Fjona, Muzammil, Taimur S., Kochhar, Gursimran , Khataniar, Himsikhar , Muzammil, Taimur Sohail, Hashash, Jana G. , Farraye, Francis A. , Desai, Aakash

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S786-S787

10.14309/01.ajg.0001033800.13615.92 Get It

S1106 Comparative Outcomes of Eosinophilic Esophagitis in Patients With and Without Inflammatory Bowel Disease: A Propensity-Matched Cohort Study
Tabaku, Fjona, Kochhar, Gursimran , Khataniar, Himsikhar , Desai, Aakash , Hashash, Jana G. , Farraye, Francis A.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S784-S785

10.14309/01.ajg.0001033792.74227.98 Get It

Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice
Dizman, Nazlı , Bakouny, Ziad , Haykal, Tarek , Riaño, Ivy , Desai, Aakash , Butt, Ayesha , Basu, Arnab , Zhao, Dan , Saad, Eddy , Saliby, Renée Maria , Gosain, Rohit , Gosain, Rahul , Ardeshir, Fatemeh , Matt-Amaral, Laurie , Arnaoutakis, Konstantinos , Bekaii‐Saab, Tanios , Marshall, Ariela L. , Murphy, Martina, Lopes, Gilberto , Lee, Alfred Ian , Deng, Lei , Matt-Amaral, Laurie , Arnaoutakis, Konstantinos , Bekaii-Saab, Tanios S , Manochakian, Rami , Marshall, Ariela , Forde, Patrick , Subbiah, Vivek , Chavez-MacGregor, Mariana , Owonikoko, Taofeek Kunle , Lopes, Gilberto , Aggarwal, Charu , Lee, Alfred I , Choueiri, Toni K , Desai, Aakash P , Bakouny, Ziad , Basu, Arnab , Butt, Ayesha , Zhao, Dan , Saad, Eddy , Deng, Lei , Manochakian, Rami , Forde, Patrick M. , Subbiah, Vivek , Chávez‐MacGregor, Mariana , Aggarwal, Charu , Choueiri, Toni K.

Mayo Clinic

JCO Oncology Practice | October 7, 2024 | Volume: 21 | Issue: 3 | Pages: 292-299

10.1200/op-24-00565 | PMID 39374449 Get It

PURPOSE International medical graduates (IMGs) are an essential component of the oncology workforce in the United States, comprising a third of all practicing oncologists and almost half of hematology/oncology fellows. In this article, we discuss the contributions of IMGs in the US oncology workforce, review unique challenges faced by IMGs, and propose potential solutions to overcome these challenges. METHODS ASCO's IMG Community of Practice was established with the mission to connect, mentor, guide, raise awareness, and overcome the challenges unique to IMGs interested in pursuing medical oncology in the United States. The content of this article is based on discussions at the IMG Community of Practice meetings at ASCO's 2023 and 2024 Annual Meetings. RESULTS IMGs bring an inherent diversity of thought and experience to the oncology workforce. They provide high-quality, culture- and language-concordant care to a diverse population of patients with cancer. However, IMGs in oncology face significant hardships throughout their careers, including visa-related restrictions, psychosocial and cultural struggles, as well as differential treatment while applying for residency and fellowship training, and early career positions. Greater awareness of these challenges among the members of the hematology/oncology community, along with institutional and individual efforts to support IMGs, is warranted. CONCLUSION We encourage oncology professionals and institutions to join our efforts in recognizing the unique paths of IMGs and providing support and advocacy to maximize the potential of IMGs in the US oncology workforce.